Fosfomycin Trometamol Powder - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

What is Fosfomycin Trometamol Powder - Global Market?

Fosfomycin Trometamol Powder is a significant player in the global pharmaceutical market, primarily due to its effectiveness in treating bacterial infections, particularly urinary tract infections (UTIs).

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-21D7972/global-and-china-fosfomycin-trometamol-powder

Purity 99%, Purity: Above 99% in the Fosfomycin Trometamol Powder - Global Market:

This compound is a derivative of phosphonic acid and is known for its broad-spectrum antibacterial properties.

Common Urinary Tract Infection, Postoperative Urinary Tract Infection, Preoperative Prevention of Urinary Tract Infection in the Fosfomycin Trometamol Powder - Global Market:

It works by inhibiting bacterial cell wall synthesis, making it a potent option against a variety of gram-positive and gram-negative bacteria.

Fosfomycin Trometamol Powder - Global Market Outlook:

The global market for Fosfomycin Trometamol Powder is driven by the increasing prevalence of UTIs, the rising demand for effective antibiotics, and the growing awareness of antibiotic resistance.

Get Free Sample Report: https://reports.valuates.com/request/sample/QYRE-Auto-21D7972/global-and-china-fosfomycin-trometamol-powder

Report Metric	Details
Report Name	Fosfomycin Trometamol Powder - Market
Forecasted market size in 2030	US$ 41 million
CAGR	3.6%
Forecasted years	2024 - 2030
Segment by Type:	Purity 99% Purity: Above 99%
Segment by Application	Common Urinary Tract Infection Postoperative Urinary Tract Infection Preoperative Prevention of Urinary Tract Infection
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Zambon, Northeast Pharm, Hunan Huana Pharmaceuticals, Xunda Pharma, FarmaSino Pharmaceutical, Guilin Hwasun
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends